NervGen Pharma Corp (NGEN) Price Prediction & ForecastNGENNervGen Pharma Corp

Alphio's NGEN stock price prediction model matches the current NervGen Pharma Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.36 (+1.83%). The 1-week path is $2.40 (+3.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nervgen Pharma appears to be a good buy right now, given its current price of $2.28, a recent RSI of 83.719 indicating strong momentum, and a projected price target of $15 from H.C. Wainwright. The positive catalysts include a public offering that raised $60 million for clinical studies and a Buy rating from TD Cowen, projecting peak sales of $1.1 billion for NVG-291. However, the main risk is the significant year-to-date change of -63.52%, indicating past volatility and potential investor concerns.

NervGen Pharma Corp (NGEN) last closed at $2.32, gaining +4.98%. These facts feed the 1-day and 1-week NGEN price prediction above.